# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-023460
Filing Date
2025-05-08
Accepted
2025-05-08 07:29:11
Documents
95
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | akba-20250331.htm iXBRL | 10-Q | 1926047
2 | EX-31.1 | exhibit311-q120251.htm | EX-31.1 | 10971
3 | EX-31.2 | exhibit312-q120251.htm | EX-31.2 | 11031
4 | EX-32.1 | exhibit321-q120251.htm | EX-32.1 | 7527
10 | GRAPHIC | akba-20250331_g1.gif | GRAPHIC | 3995
| Complete submission text file | 0001628280-25-023460.txt |  | 9500722

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | akba-20250331.xsd | EX-101.SCH | 83707
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | akba-20250331_cal.xml | EX-101.CAL | 81914
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | akba-20250331_def.xml | EX-101.DEF | 371698
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | akba-20250331_lab.xml | EX-101.LAB | 852674
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | akba-20250331_pre.xml | EX-101.PRE | 622933
98 | EXTRACTED XBRL INSTANCE DOCUMENT | akba-20250331_htm.xml | XML | 1125064

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 25923877
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)